Cargando…
Camelid V(H)H affinity ligands enable separation of closely related biopharmaceuticals
Interest in new and diverse classes of molecules such as recombinant toxins, enzymes, and blood factors continues to grow for use a biotherapeutics. Compared to monoclonal antibodies, these novel drugs typically lack a commercially available affinity chromatography option, which leads to greater pro...
Autores principales: | Pabst, Timothy M., Wendeler, Michaela, Wang, Xiangyang, Bezemer, Sandra, Hermans, Pim, Hunter, Alan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY‐VCH Verlag
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333455/ https://www.ncbi.nlm.nih.gov/pubmed/27677057 http://dx.doi.org/10.1002/biot.201600357 |
Ejemplares similares
-
Implementation of Novel Affinity Ligand for Lentiviral Vector Purification
por: Moreira, Ana Sofia, et al.
Publicado: (2023) -
Application of affinity capillary electrophoresis for charge heterogeneity profiling of biopharmaceuticals
por: Hutanu, Andrei, et al.
Publicado: (2019) -
Camelid Vaccinations
por: Long, Patrick O.
Publicado: (2014) -
Camelids Are Not Ruminants
por: Fowler, Murray E.
Publicado: (2008) -
Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein
por: Mahajan, Sai Pooja, et al.
Publicado: (2018)